Advertisement

NRC

NRC Health

Healthcare · USD

Set alert

Price alert · NRC

All alert types
23.83 USD +0.34 +1.45%
As of Oct 30, 2026 Extended hours 23.83 0.00%
Bid
23.79 × 2
Ask
23.88 × 2
23.47 Day range 24.01
12.03 52-week range 23.83
YTD
+26.96%
1 year
+81.91%
Open
23.64
Prev close
23.49
Mkt cap
505.71M
Vol
86.22K
Avg vol
116.50K
EPS
0.27
P/E
88.26
Div yield
2.80%
More statistics
Low
23.47
High
24.01
Forward P/E
15.38
Beta
0.53
Short ratio
4.02
Inst. own
52.02%
Dividend
0.48
Ex-div date
Dec 26, 2024
Earnings
Feb 11, 2025
50-d avg
18.96
200-d avg
25.47
1y target
0.00

2Y chart

Chart tools
Interval
NRC two-year price chart9.7613.417.120.724.4Oct 24Mar 25Aug 25Jan 26Jun 26Oct 26

Key statistics

Market cap
418.81M
Enterprise value
453.93M
Trailing P/E
15.93
Forward P/E
15.38
PEG ratio
0.00
Price / sales
2.91
Price / book
12.09
EPS (TTM)
1.12
Beta
0.53
Dividend yield
2.80%
Payout ratio
42.86%
Profit margin
18.79%
Revenue (TTM)
144.16M
Revenue growth
-5.60%
Free cash flow
21.74M
Total cash
3.46M
Total debt
54.30M
Return on equity
58.56%
Shares outstanding
23.48M
Short % of float
2.95%
50-day average
18.96
200-day average
25.47

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Feb 11, 2025

Expected Feb 11, 2025. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
NRC Revenue — quarterly 35.39M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NRC Net income — quarterly -3.28M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
NRC EPS — quarterly -0.15
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

NRC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 11, 2025Dec 1, 20240.00———
Oct 25, 2024Sep 1, 20240.000.24——
Aug 6, 2024Jun 1, 20240.000.26——
May 7, 2024Mar 1, 20240.000.27——
Feb 13, 2024Dec 1, 20230.000.36——
Nov 7, 2023Sep 1, 20230.000.32——

About NRC Health

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Sector
Healthcare
Industry
Health Information Services
Country
United States

News

Your note

Sign in to keep a note on NRC — it syncs with the Stock Master app.

Insider holders

NRC insider holders
InsiderRelationLatest transactionDateShares held
AMANDLA MK TRUSTBeneficial Owner of more than 10% of a Class of SecuritySaleJan 4, 20240
COMMON PROPERTY TRUSTBeneficial Owner of more than 10% of a Class of SecuritySaleFeb 29, 20240
HAYS MICHAEL DChief Executive OfficerConversion of Exercise of derivative securityJan 1, 202477,090
KARAS KEVIN RChief Financial OfficerSaleFeb 27, 20235,384
NUNNELLY JOHN NDirectorConversion of Exercise of derivative securityMar 26, 202432,666
RAASCH JONA SOfficerSaleApr 2, 20230

Institution ownership

NRC institution ownership
Holder% heldSharesValueReported
Kayne Anderson Rudnick Investment Management LLC13.03%3,059,57654.58MSep 29, 2024
Blackrock Inc.4.96%1,164,25620.77MSep 29, 2024
Vanguard Group Inc4.20%986,37017.60MSep 29, 2024
Morgan Stanley3.91%918,75716.39MSep 29, 2024
Dimensional Fund Advisors LP2.52%590,79710.54MSep 29, 2024
Geode Capital Management, LLC1.79%420,7337.51MSep 29, 2024

Fund ownership

NRC fund ownership
Holder% heldSharesValueReported
Virtus Equity Tr-Virtus KAR Small Cap Growth Fd8.55%2,008,00935.82MSep 29, 2024
Vanguard Total Stock Market Index Fund2.51%589,02210.51MSep 29, 2024
iShares Russell 2000 ETF1.58%371,6576.63MOct 30, 2024
Vanguard Extended Market Index Fund1.04%243,5294.34MSep 29, 2024
DFA U.S. Micro Cap Series0.95%222,6203.97MJul 30, 2024
Fidelity Small Cap Index Fund0.66%155,3612.77MAug 30, 2024
Advertisement